The landscape of diabetes management in the United States has experienced a monumental shift. Global healthcare leader Abbott has officially announced that the U.S. Food and Drug Administration (FDA) has granted authorization for its revolutionary Libre Duo 10 Day system . This milestone marks the world’s very first dual glucose-ketone sensing technology, establishing an unprecedented standard in continuous biowearable health monitoring. Designed explicitly to protect individuals living with diabetes, this groundbreaking device targets the silent and rapid threat of diabetic ketoacidosis (DKA), an acute and life-threatening complication. For millions of Americans navigating the complexities of type 1 and type 2 diabetes, traditional glucose monitoring has long been the primary defensive line. However, tracking blood sugar alone often leaves a critical blind spot: rising ketone levels. With the introduction of Abbott’s new dual-sensing technology, patients and healthcare providers g...
Explore the Universe of Nature: fact-checked ideas on global wildlife, space science, and human environmental impact. Get inspired by documented natural wonders.